These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 17315190
1. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P, Sutmuller RP, Adema GJ. Int J Cancer; 2007 Jul 01; 121(1):95-105. PubMed ID: 17315190 [Abstract] [Full Text] [Related]
2. Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. El Andaloussi A, Han Y, Lesniak MS. J Neurosurg; 2006 Sep 01; 105(3):430-7. PubMed ID: 16961139 [Abstract] [Full Text] [Related]
7. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response. Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Xenotransplantation; 2012 Sep 01; 19(2):102-11. PubMed ID: 22497512 [Abstract] [Full Text] [Related]
8. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T, Sakaguchi S. J Exp Med; 2005 Oct 03; 202(7):885-91. PubMed ID: 16186187 [Abstract] [Full Text] [Related]
9. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY. Chin Med J (Engl); 2010 Apr 05; 123(7):942-8. PubMed ID: 20497692 [Abstract] [Full Text] [Related]
10. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis. Coleman MM, Finlay CM, Moran B, Keane J, Dunne PJ, Mills KH. FEMS Immunol Med Microbiol; 2012 Apr 05; 64(3):413-24. PubMed ID: 22211712 [Abstract] [Full Text] [Related]
11. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. Fragale A, Gabriele L, Stellacci E, Borghi P, Perrotti E, Ilari R, Lanciotti A, Remoli AL, Venditti M, Belardelli F, Battistini A. J Immunol; 2008 Aug 01; 181(3):1673-82. PubMed ID: 18641303 [Abstract] [Full Text] [Related]
12. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells. Wang B, Li B, Dai Z, Ren S, Bai M, Wang Z, Li Z, Lin S, Wang Z, Huang N, Yang P, Liu M, Min W, Ma H. Int J Biochem Cell Biol; 2014 Oct 01; 55():98-108. PubMed ID: 25168696 [Abstract] [Full Text] [Related]
13. Providence of the CD25+ KIR+ CD127- FOXP3- CD8+ T-cell subset determines the dynamics of tumor immune surveillance. Chakraborty S, Bhattacharjee P, Panda AK, Kajal K, Bose S, Sa G. Immunol Cell Biol; 2018 Nov 01; 96(10):1035-1048. PubMed ID: 29768737 [Abstract] [Full Text] [Related]
15. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells. Kaur G, Goodall JC, Jarvis LB, Hill Gaston JS. Mol Immunol; 2010 Nov 01; 48(1-3):321-32. PubMed ID: 20688398 [Abstract] [Full Text] [Related]
16. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice. Javeed A, Zhang B, Qu Y, Zhang A, Sun C, Zhang L, Liu J, Zeng C, Zhao Y. Transpl Immunol; 2009 Mar 01; 20(4):253-60. PubMed ID: 19146957 [Abstract] [Full Text] [Related]
18. An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme. El Andaloussi A, Lesniak MS. Neuro Oncol; 2006 Jul 01; 8(3):234-43. PubMed ID: 16723631 [Abstract] [Full Text] [Related]